FocusPerformancePartnership
How We Partner

One partnership approach. Shared ambitions.

As a partner-owned firm, we build long-term relationships with management teams and investors - aligned around a shared objective: delivering performance through disciplined execution and sustained value creation.

How We Partner
Shutterstock 210633202
16
Active Partners

A partner-owned firm

Astorg is one of Europe’s longest-standing independent private equity firms, with over 25 years of investment experience.

Led by a cohesive group of partners and supported by an international team of around 200 professionals, we combine continuity of leadership with a long-term perspective. This enables agile decision-making, and to act with consistency, discipline and conviction across cycles.

Management Teams

Partnering with management teams

We partner with founders and management teams to build stronger, more valuable businesses over time.

Our approach is hands-on, entrepreneurial and tailored to each situation. We combine close collaboration with clear expectations, bringing both support and challenge while addressing difficult topics early.

Our sector depth - built across decades of investing - allows us to engage with relevance from day one. We understand the strategic context, operational challenges and the levers that matter, and align early on priorities, performance ambitions and the leadership required to deliver.  In primary transactions, we often partner directly with founders, families or management teams, frequently as their first institutional investment partner.

We build trust through consistency, transparency and delivery. We work alongside management teams over time to support execution and achieve shared ambitions.

We ListenWe AlignWe TrustWe ListenWe AlignWe TrustWe ListenWe AlignWe TrustWe ListenWe AlignWe TrustWe ListenWe AlignWe Trust

How we work together

We listen

We believe in the art of listening. We take the time to understand each business - its strategy, culture and ambitions. This allows us to build a shared perspective and engage in a constructive, informed dialogue.

We align

We work with management teams to define a clear path to value creation. Together, we shape priorities, performance objectives and the value creation plan, supported by our Portfolio Performance team.

We build trust

We are active owners - present, responsive and engaged throughout the investment journey. We work alongside management teams to support execution and deliver results.

10574 Lau 3841©laurinepaumardphotographe
co-investors

Partnering with co-investors

Partnership extends beyond the companies we invest in. We build long-term relationships with our investors based on transparency, alignment and trust, with a focus on consistent communication and performance over time.

We have built one of the industry’s most active co-investment programs.  When the equity required for an investment allows, we offer co-investment opportunities to all our investors.

This allow our co-investment partners to increase exposure to businesses they select, while benefiting from the same sourcing, underwriting and active ownership approach that characterizes our investment strategy.

It is another way to align interests and build long-term partnerships.

340
LPs across the globe
€7bn
Total co-investments offered since Astorg V
60%
Portfolio companies with co-investments since Astorg V
Jean Raby

"Our co-investment programme is an integral part of our partnership culture. It gives all investors the opportunity to invest alongside us on a management-fee and carry-free basis, and to participate directly in the value we build together in the asset they select.”

Jean Raby

Partner, Chief Client and Business Development Officer

Astorg completes acquisition of Microbiology business from Thermo Fisher Scientific, establishing an independent global diagnostics specialist
ViewMore
Healthcare
news
Astorg completes acquisition of Microbiology business from Thermo Fisher Scientific, establishing an independent global diagnostics specialist
Astorg-backed CordenPharma acquires AmbioPharm, strengthening its position as a leading global peptide development and manufacturing platform
ViewMore
Healthcare
news
Astorg-backed CordenPharma acquires AmbioPharm, strengthening its position as a leading global peptide development and manufacturing platform
Astorg-backed Steliau to acquire Acal BFI, strengthening its position as the leading European platform in value-added electronic solutions
ViewMore
Technology
news
Astorg-backed Steliau to acquire Acal BFI, strengthening its position as the leading European platform in value-added electronic solutions
Astorg to acquire global microbiology business from Thermo Fisher Scientific
ViewMore
Healthcare
news
Astorg to acquire global microbiology business from Thermo Fisher Scientific
Astorg Mid Cap to acquire Barkene, a leading multi-specialist B2B technical services platform
ViewMore
Business Services
news
Astorg Mid Cap to acquire Barkene, a leading multi-specialist B2B technical services platform
Solabia accelerates expansion plan with three strategic acquisitions
ViewMore
Healthcare
news
Solabia accelerates expansion plan with three strategic acquisitions
Astorg completes acquisition of Microbiology business from Thermo Fisher Scientific, establishing an independent global diagnostics specialist
ViewMore
Healthcare
news
Astorg completes acquisition of Microbiology business from Thermo Fisher Scientific, establishing an independent global diagnostics specialist
Astorg-backed CordenPharma acquires AmbioPharm, strengthening its position as a leading global peptide development and manufacturing platform
ViewMore
Healthcare
news
Astorg-backed CordenPharma acquires AmbioPharm, strengthening its position as a leading global peptide development and manufacturing platform
Astorg-backed Steliau to acquire Acal BFI, strengthening its position as the leading European platform in value-added electronic solutions
ViewMore
Technology
news
Astorg-backed Steliau to acquire Acal BFI, strengthening its position as the leading European platform in value-added electronic solutions
Astorg to acquire global microbiology business from Thermo Fisher Scientific
ViewMore
Healthcare
news
Astorg to acquire global microbiology business from Thermo Fisher Scientific
Astorg Mid Cap to acquire Barkene, a leading multi-specialist B2B technical services platform
ViewMore
Business Services
news
Astorg Mid Cap to acquire Barkene, a leading multi-specialist B2B technical services platform
Solabia accelerates expansion plan with three strategic acquisitions
ViewMore
Healthcare
news
Solabia accelerates expansion plan with three strategic acquisitions